Leerink Partnrs Reduces Earnings Estimates for CVS Health

CVS Health Co. (NYSE:CVS) – Investment analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for shares of CVS Health in a report issued on Wednesday, December 18th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings per share of $0.98 for the quarter, down from their previous estimate of $1.24. The consensus estimate for CVS Health’s current full-year earnings is $5.32 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.66 EPS.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.21 earnings per share.

CVS has been the topic of a number of other reports. TD Cowen upped their price target on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. UBS Group upped their target price on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Finally, StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $69.12.

CVS Health Stock Up 1.3 %

Shares of CVS Health stock opened at $44.36 on Monday. CVS Health has a 52-week low of $43.60 and a 52-week high of $83.25. The firm’s 50 day moving average price is $56.24 and its 200-day moving average price is $58.23. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market cap of $55.82 billion, a P/E ratio of 11.26, a PEG ratio of 0.85 and a beta of 0.54.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Assetmark Inc. increased its holdings in shares of CVS Health by 9.7% during the 3rd quarter. Assetmark Inc. now owns 410,001 shares of the pharmacy operator’s stock valued at $25,781,000 after purchasing an additional 36,132 shares in the last quarter. TD Private Client Wealth LLC increased its holdings in CVS Health by 28.7% in the third quarter. TD Private Client Wealth LLC now owns 46,938 shares of the pharmacy operator’s stock valued at $2,951,000 after buying an additional 10,465 shares in the last quarter. Cullinan Associates Inc. raised its position in shares of CVS Health by 43.8% in the third quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator’s stock worth $7,125,000 after acquiring an additional 37,395 shares during the period. Sompo Asset Management Co. Ltd. grew its position in shares of CVS Health by 8.4% during the 3rd quarter. Sompo Asset Management Co. Ltd. now owns 134,523 shares of the pharmacy operator’s stock valued at $8,459,000 after acquiring an additional 10,453 shares during the period. Finally, Deerfield Management Company L.P. Series C purchased a new position in shares of CVS Health in the 2nd quarter valued at about $57,584,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.